MFN Drug Pricing Targets: Lowering U.S. Drug Co...

By Rene Pretorius

May 21, 2025

Summary The U.S. Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) have set Most-Favored-Nation (MFN)
HTA Reform Analysis: Patterns and Global Trends in Health Technology Assessment
Drug Pricing Analysis: ICER’s Launch Price and Access Report Aims to En...
Trends in Anticancer Drug Pricing: Analyzing Medicare Launch Prices and Impac...
EMA AI Tool Qualification: How the AIM-NASH Approval Sets a Roadmap for Medic...
Publication Delays Impact Careers of Early-Career Researchers
A System Dynamics Approach to Lowering Drug Prices by 30–80% in the US
EFPIA Advocates for Stronger Life Sciences in EU Multiannual Financial Framework
Evolving NICE Health Technology Evaluations: Enhancing Patient Perspectives a...
Canada Drug Agency Plan: Shaping the Future of Health Systems 2025-2030
VIETNARMS Trial Unveils Innovative Hepatitis C Treatment Options
Revolutionizing Hepatitis C Treatment: The Transformative Role of Direct-Acti...
Hepatitis C Investment Impact: Maximizing Health and Economic Returns in China